$48.99 $1.63 per serving
Product analysis
Clari-T combines bacopa and ginkgo for memory and attention support, but expected benefits remain uncertain. Its unidentified extracts cannot be assumed to match the preparations behind the more promising findings.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality35
Several ingredients have named sources or compounds, but the exact extract preparations remain unclear. Their absorption characteristics and consistency cannot be judged confidently.
Ingredient Transparency70
All ingredient amounts and most forms are stated, helping compare servings. Ginger and vinpocetine lack form details, and ginkgo blend proportions are omitted.
Value For Money31
The defined comparisons point to limited value for bacopa and vinpocetine and an expensive serving when considered for ginger. The other ingredients do not provide enough price information for a confident value conclusion.
Customer Satisfaction74
Customer feedback is very positive across a few hundred reviews. The moderate review history gives a useful but limited picture of satisfaction.
Product Focus58
The main intent is memory and attention support, with inconsistent evidence for stress relief. Unidentified extracts limit expectations for routine focus or productivity benefits.
- Format
Capsule - Container
- 60 Capsule(s)
- Per serving
- $1.63
- Customer rating
- 4.7 · 218 ratings
Goals
Impact
Moderate effect
Bacopa · 425 mg
Bacopa and ginkgo relate to different aspects of cognitive support: selected memory outcomes after repeated bacopa use and preliminary acute attention-speed findings for specific ginkgo preparations. The 425 mg bacopa and 120 mg ginkgo are unidentified extracts, which limits transfer from those trials.
Phosphatidylserine is a membrane phospholipid, but its general cognitive evidence is inconsistent. Huperzine sources and the other cognitive-intent ingredient do not add supported routine benefits in the supplied evidence.
How this product is rated for Cognitive Support
Ingredient fit82
Bacopa, ginkgo and phosphatidylserine provide a focused combination with a strong saved exposure match.
Goal fit
Bacopa, ginkgo and phosphatidylserine provide a focused combination with a strong saved exposure match..
Dose adequacy
Bacopa and ginkgo meet the saved exposure references, while phosphatidylserine contributes a partial match.
Pathways60
Oxidative and inflammatory protection and cerebral blood flow is the main area represented in the saved findings. Two core areas reach meaningful coverage, giving partial breadth.
Depth
Oxidative and inflammatory protection and cerebral blood flow is the main area represented in the saved findings.
Breadth
Two core areas reach meaningful coverage, giving partial breadth.
Evidence27
Bacopa supplies the strongest effective evidence in the saved finding, with preparation uncertainty across the combination. The relevant material is not identified as a studied cognitive preparation.
Evidence strength
Bacopa supplies the strongest effective evidence in the saved finding, with preparation uncertainty across the combination.
Studied preparation
The relevant material is not identified as a studied cognitive preparation.
Formulation logic100
The relevant ingredients can contribute without an additional required partner. All ingredients counted in the saved effective-exposure finding reach its minimum level.
Partner coverage
The saved assessment finds no missing required partner for the relevant ingredients.
Conflicts
No listed cognitive-performance conflict was found in the supplied assessment.
Effective doses
All ingredients counted in the saved effective-exposure finding reach its minimum level.
Phospholipids (unspecified) Not classified
No linked studies yet.
Impact
High effect
Ginkgo has mixed findings on acute cognitive tasks, without reliable evidence for sustained concentration from generic material. Bacopa's limited acute findings depend on identified CDRI 08 extract, which this whole-plant extract does not establish. Vinpocetine and phosphatidylserine do not have supplied evidence establishing routine immediate focus enhancement. The saved ingredient and pathway findings therefore exceed what can be promised for one serving.
How this product is rated for Mental Focus
Ingredient fit86
Relevant ingredients share the formula with other purposes; its links to several goals also reduce its focus specificity. Declared amounts meet the saved comparison.
Goal fit
Relevant ingredients share the formula with other purposes; its links to several goals also reduce its focus specificity.
Dose adequacy
Declared amounts fully meet the saved amount comparison; this does not establish a proven effective acute-focus dose.
Pathways59
The strongest saved coverage concerns cerebral energy supply; this is not proof of improved attention.
Depth
The strongest saved coverage concerns cerebral energy supply; this is not proof of improved attention.
Breadth
Only one pathway reaches the saved coverage threshold, so the findings are concentrated rather than broad.
Evidence59
The supplied scientific qualifications limit what the saved favourable findings establish about immediate attention. Some declarations do not match studied preparations.
Evidence strength
The supplied scientific qualifications limit what the saved favourable findings establish about immediate attention.
Studied preparation
The saved preparation finding is incomplete for Bacopa; generic declarations do not establish equivalence to studied material.
Formulation logic100
No configured ingredient conflict is identified in the supplied findings. No missing partner was identified.
Partner coverage
No missing partner is identified for the ingredients included in the saved finding; this does not establish added benefit from combining them.
Conflicts
No configured ingredient conflict is identified in the supplied findings.
Effective doses
All ingredients counted by this rule meet its minimum amount threshold; that threshold is not a clinically proven dose for immediate focus.
Impact
High effect
Bacopa · 425 mg
Bacopa has modest memory-learning evidence for separately identified studied extracts, but this unidentified extract cannot be assumed equivalent. The supplied context also limits broad healthy-adult expectations for vinpocetine and ginkgo. Soy phosphatidylserine has inconsistent cognitive findings, including null main outcomes, so its presence does not establish reliable memory improvement.
How this product is rated for Brain Health
Ingredient fit85
The ingredient selection connects to brain health, with serving amounts and the formula’s wider purpose shaping how focused that connection is.
Goal fit
The formula includes brain-relevant ingredients alongside a broader mix of ingredients and intended uses.
Dose adequacy
The recognized amounts provide partial overall coverage of the saved references, rather than establishing a proven effective cognitive dose.
Pathways80
The strongest saved connection is cerebral energy metabolism; this describes the ingredient grouping rather than a demonstrated brain-health outcome. Two areas reach the saved coverage threshold, although this does not demonstrate benefits across every aspect of cognition.
Depth
The strongest saved connection is cerebral energy metabolism; this describes the ingredient grouping rather than a demonstrated brain-health outcome.
Breadth
Two areas reach the saved coverage threshold, although this does not demonstrate benefits across every aspect of cognition.
Evidence57
The saved evidence findings recognize ingredients and preparations, while the supplied scientific context limits expectations for general cognitive improvement.
Evidence strength
Vinpocetine leads the saved evidence finding, while the supplied research context limits claims of broad cognitive improvement.
Studied preparation
The saved preparation finding is incomplete: Bacopa, Phosphatidylserine lack the recognized preparation match.
Formulation logic100
The saved findings identify no missing required partners or configured conflicts. Amount recognition does not itself establish an effective cognitive outcome.
Partner coverage
The recognized ingredients have no missing required partner in the saved findings; this does not establish an added benefit from combining them.
Conflicts
No configured conflict was identified. The caffeine-specific checks do not apply because no qualifying caffeine amount is established.
Effective doses
All ingredients included in this finding meet its minimum amount threshold, which is a comparison reference rather than a proven cognitive dose.
Phospholipids (unspecified) Not classified
No linked studies yet.
Impact
Moderate effect
Bacopa may help with stress or anxiety, but the effect is inconsistent and depends on the extract. The phospholipid ingredient needs a separate qualification: unspecified phospholipids aren’t the same as a verified amount of phosphatidylserine. That distinction limits what you can expect from that part of the combination.
How this product is rated for Stress Relief
Ingredient fit60
Bacopa has an uncertain, extract-specific connection to stress and anxiety.
Goal fit
Bacopa has an uncertain, extract-specific connection to stress and anxiety.
Dose adequacy
A serving supplies 425 mg bacopa and 100 mg unspecified phospholipids; the latter does not verify a phosphatidylserine dose.
Pathways46
Mood-related processes provide the main connection, with a smaller stress-response connection.
Depth
Mood-related processes provide the main connection, with a smaller stress-response connection.
Breadth
The ingredients provide a concentrated connection rather than broad effects across different stress processes.
Evidence48
Bacopa has an uncertain, extract-specific connection to stress and anxiety. Phospholipid identity adds uncertainty.
Evidence strength
Bacopa has an uncertain, extract-specific connection to stress and anxiety.
Studied preparation
Bacopa has an applicable preparation, but unspecified phospholipids do not identify the phosphatidylserine preparation.
Formulation logic100
The relevant ingredients have no missing required partner or identified ingredient conflict.
Partner coverage
The relevant ingredients have no missing required partner.
Conflicts
No particular ingredient conflict is identified.
Effective doses
A serving supplies 425 mg bacopa and 100 mg unspecified phospholipids; the latter does not verify a phosphatidylserine dose.
Phospholipids (unspecified) Not classified
No linked studies yet.
Impact
Moderate effect
Vinpocetine · 20 mg
Bacopa at 425 mg relates mainly to memory and information processing after repeated use, though its preparation is not identified as the studied extract. Ginkgo at 120 mg adds mixed evidence for memory and attention.
Vinpocetine has limited relevance to routine productivity, and the supplied evidence for phosphatidylserine and huperzia does not support a clear everyday work benefit.
How this product is rated for Productivity Boost
Ingredient fit86
The relevant ingredients are a clear focus of the formula. The assessed amounts come close to the saved comparison benchmarks overall.
Goal fit
The relevant ingredients are a clear focus of the formula.
Dose adequacy
The assessed amounts come close to the saved comparison benchmarks overall.
Pathways40
The strongest assessed area is synaptic plasticity and neuroprotection, with moderate coverage. One assessed area reaches the saved threshold for substantial coverage.
Depth
The strongest assessed area is synaptic plasticity and neuroprotection, with moderate coverage.
Breadth
One assessed area reaches the saved threshold for substantial coverage.
Evidence37
Ginkgo provides the strongest evidence contribution among the assessed ingredients; its relevance to everyday productivity remains qualified. Preparation matching is partial; Bacopa, Vinpocetine. Shared rubric rule. lack a recognized trial-preparation match.
Evidence strength
Ginkgo provides the strongest evidence contribution among the assessed ingredients; its relevance to everyday productivity remains qualified.
Studied preparation
Preparation matching is partial; Bacopa, Vinpocetine. Shared rubric rule. lack a recognized trial-preparation match.
Formulation logic100
The assessed ingredients can contribute independently or have their required partner. No configured ingredient conflict was matched in the supplied assessment. All ingredients included in this check reach its minimum amount threshold.
Partner coverage
The assessed ingredients can contribute independently or have their required partner.
Conflicts
No configured ingredient conflict was matched in the supplied assessment.
Effective doses
All ingredients included in this check reach its minimum amount threshold.
Vinpocetine Not classified
No linked studies yet.
Impact
Lower effect
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Bacopa whole plant extract (Bacosides) | 425 mg | |
Ginkgo leaf extract (Terpene Lactones, Flavone Glycosides) | 120 mg | |
Phosphatidylserine (non-GMO Soy Lecithin) | 100 mg | |
Ginger | 50 mg | |
Toothed Clubmoss aerial extract (Huperzine A) | 20 mg | |
Vinpocetine | 20 mg |
Vinpocetine · 20 mg OverallScore80
Vinpocetine is listed separately at 20 mg per serving, an amount favored in the evaluation. Based on the whole-product price, it costs about $0.82 per 10 mg of vinpocetine, a high cost for that amount.
How this ingredient is rated
Active Ingredient Quality & Bioavailability91
Vinpocetine is identified by name, while its source form is unresolved in the saved data. The evaluation recognizes ordinary excipients.
Vinpocetine Identity and Source
Vinpocetine is identified by name with 20 mg per serving; its source form is unresolved in the saved data.
Excipient and Filler Quality
The evaluation recognizes ordinary excipients; this does not establish that the product is additive-free.
Dose, Safety & Label Transparency100
The 20 mg serving amount is separately disclosed, making the vinpocetine quantity clear.
Vinpocetine Dosage Alignment
The serving contains 20 mg of vinpocetine, an amount favored in the evaluation.
Proprietary Blend Disclosure
The individual vinpocetine amount is disclosed as 20 mg per serving.
Value20
The whole-product price works out to about $0.82 per 10 mg of vinpocetine, a high cost for that amount.
Cost Efficiency per 10mg Dose
Based on the whole-product price, 10 mg of vinpocetine costs about $0.82, a high cost for that amount.
Ginkgo (Terpene Lactones, Flavone Glycosides) · 120 mg OverallScore85
A serving provides 120 mg of ginkgo leaf extract, with recorded marker levels of 24% flavones and 6% terpenes. Those marker levels help compare its composition with other ginkgo preparations.
How this ingredient is rated
Composition and Label Disclosure70
Both flavone and terpene marker levels are recorded for the ginkgo. No ginkgolic acid limit is available in the saved facts.
Marker and Preparation Disclosure
The saved facts record 24% flavones and 6% terpenes.
Declared Ginkgolic Acid Limit
The saved facts do not contain a qualifying ginkgolic acid limit; the actual level is unknown.
Composition and Label Disclosure100
The ginkgo amount is individually recorded as 120 mg per serving.
Individual Preparation Amount Disclosure
The selected serving contains 120 mg of ginkgo leaf extract.
Commercial Price and Usability
No value assessment was included for ginkgo.
Bacopa (Bacosides) · 425 mg OverallScore77
Each serving provides 425 mg of Bacopa extract, recorded as 20% bacosides. The whole-product serving costs about $1.63.
How this ingredient is rated
Composition and Label Disclosure
No separate composition or bioavailability rules were evaluated.
Composition and Label Disclosure100
The saved information records 425 mg of Bacopa extract per serving and 20% bacosides.
Amount and Label Disclosure
The saved information records 425 mg of Bacopa extract per serving and 20% bacosides.
Commercial Price and Usability30
The whole-product serving costs about $1.63; this is not a price for Bacopa alone.
Commercial Price per Labeled Serving
The recorded whole-product price is about $1.63 per serving, not a separate Bacopa price.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis.
- Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract.
- Comparative efficacy of Medhya Rasayana,Bacopa monnieri, and Centella asiatica in enhancing memory and IQ of 8-10 year-old healthy boys: A prakriti-based double-blind, randomized controlled trial.
- Plant-derived nootropics and human cognition: A systematic review.
- The effect of plant active substances on cognitive function in healthy older adults: a systematic review and network meta-analysis of randomized controlled trials.
- Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
- Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
- Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
- Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
- Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
- Combination of Vinpocetine and Dexamethasone Alleviates Cognitive Impairment in Nasopharyngeal Carcinoma Patients following Radiation Injury.
- Effects of vinpocetine on the redistribution of cerebral blood flow and glucose metabolism in chronic ischemic stroke patients: a PET study.
- Role of sodium channel inhibition in neuroprotection: effect of vinpocetine.
- Effect of vinpocetine (cognitol™) on cognitive performances of a nigerian population.
- [Study of the effects of vinpocetin on cognitive functions].
- The cognitive-enhancing effects of Bacopa monnieri: a systematic review of randomized, controlled human clinical trials.
- A systematic review of the Ayurvedic medicinal herb Bacopa monnieri in child and adolescent populations.
- Efficacy of Standardized Extract of Bacopa monnieri (Bacognize®) on Cognitive Functions of Medical Students: A Six-Week, Randomized Placebo-Controlled Trial.
- Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
- A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.